At HLTH 2025, Ian Khan sits down with Matthias Kleinz, Executive Vice President of Translational Sciences at UPMC Enterprises, to discuss turning science into ventures. UPMC Enterprises is the innovation and commercialization arm of UPMC, translating research into companies and products. Kleinz shares how translational science bridges the lab and the market. The conversation explores how a leading health system builds and scales new healthcare ventures.